Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics

P. S. Lietman

Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics

P. S. Lietman

School of Medicine

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Abstract

The pharmacodynamics and pharmacokinetics of beta-lactam antibiotics in patients with cystic fibrosis are discussed. A hypothetical dosing regimen based on these principles is considered. The usual dosing regimens may be suboptimal. New dosage regimens should be studied using prospective, controlled, randomized and blinded clinical trials.

Original language	English (US)
Pages (from-to)	115S-119S
Journal	CHEST
Volume	94
Issue number	2 SUPPL.
State	Published - Jan 1 1988

ASJC Scopus subject areas

Pulmonary and Respiratory Medicine
Critical Care and Intensive Care Medicine
Cardiology and Cardiovascular Medicine

Cite this

@article{90e82405f97e4fd7a0b3e6f0726120df,

title = "Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics",

abstract = "The pharmacodynamics and pharmacokinetics of beta-lactam antibiotics in patients with cystic fibrosis are discussed. A hypothetical dosing regimen based on these principles is considered. The usual dosing regimens may be suboptimal. New dosage regimens should be studied using prospective, controlled, randomized and blinded clinical trials.",

author = "Lietman, {P. S.}",

year = "1988",

month = jan,

day = "1",

language = "English (US)",

volume = "94",

pages = "115S--119S",

journal = "CHEST",

issn = "0012-3692",

publisher = "American College of Chest Physicians",

number = "2 SUPPL.",

}

TY - JOUR

T1 - Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics

AU - Lietman, P. S.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The pharmacodynamics and pharmacokinetics of beta-lactam antibiotics in patients with cystic fibrosis are discussed. A hypothetical dosing regimen based on these principles is considered. The usual dosing regimens may be suboptimal. New dosage regimens should be studied using prospective, controlled, randomized and blinded clinical trials.

AB - The pharmacodynamics and pharmacokinetics of beta-lactam antibiotics in patients with cystic fibrosis are discussed. A hypothetical dosing regimen based on these principles is considered. The usual dosing regimens may be suboptimal. New dosage regimens should be studied using prospective, controlled, randomized and blinded clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=0023793070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023793070&partnerID=8YFLogxK

M3 - Article

C2 - 3293936

AN - SCOPUS:0023793070

SN - 0012-3692

VL - 94

SP - 115S-119S

JO - CHEST

JF - CHEST

IS - 2 SUPPL.

ER -

Pharmacokinetics of antimicrobial drugs in cystic fibrosis. β-Lactam antibiotics

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this